Literature DB >> 22212427

A hearty solution for acute myeloid leukemia.

Yi-ju Hung1, H Eugene Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22212427      PMCID： PMC4010277          DOI： 10.1038/aps.2011.197

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  15 in total

1.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

2.  Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay.

Authors:  R Selden; T W Smith
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

3.  Is digitalis a therapy for breast carcinoma?

Authors:  B Stenkvist
Journal:  Oncol Rep       Date:  1999 May-Jun       Impact factor: 3.906

4.  Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia.

Authors:  M Tailler; L Senovilla; E Lainey; S Thépot; D Métivier; M Sébert; V Baud; K Billot; P Fenaux; L Galluzzi; S Boehrer; G Kroemer; O Kepp
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

5.  Cardiac glycosides and breast cancer, revisited.

Authors:  B Stenkvist; E Bengtsson; B Dahlqvist; O Eriksson; T Jarkrans; B Nordin
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

6.  Phase 1 trial of Anvirzel in patients with refractory solid tumors.

Authors:  Tarek Mekhail; Hanspreet Kaur; Ram Ganapathi; G Thomas Budd; Paul Elson; Ronald M Bukowski
Journal:  Invest New Drugs       Date:  2006-09       Impact factor: 3.850

7.  Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.

Authors:  M L Guzman; S J Neering; D Upchurch; B Grimes; D S Howard; D A Rizzieri; S M Luger; C T Jordan
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.

Authors:  B Stamatopoulos; N Meuleman; C De Bruyn; P Mineur; P Martiat; D Bron; L Lagneaux
Journal:  Leukemia       Date:  2009-08-27       Impact factor: 11.528

9.  Elevated concentrations of endogenous ouabain in patients with congestive heart failure.

Authors:  S S Gottlieb; A C Rogowski; M Weinberg; C M Krichten; B P Hamilton; J M Hamlyn
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

Review 10.  Novel therapeutic applications of cardiac glycosides.

Authors:  Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2008-10-24       Impact factor: 84.694
View more
  1 in total

1.  Digoxin reduces the mutagenic effects of Mitomycin C in human and rodent cell lines.

Authors:  Júlia Teixeira de Oliveira; Maria C da Silva Barbosa; Luiz F de Camargos; Isabella Viana Gomes da Silva; Fernando de Pilla Varotti; Luciana M da Silva; Leonardo Marmo Moreira; Juliana Pereira Lyon; Vanessa J da Silva Vieira Dos Santos; Fabio Vieira Dos Santos
Journal:  Cytotechnology       Date:  2017-03-20       Impact factor: 2.058
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.